LEADER 02564nam 2200565Ia 450 001 9910450095303321 005 20200520144314.0 010 $a1-282-08350-3 010 $a9786612083501 010 $a0-309-55211-7 035 $a(CKB)1000000000030493 035 $a(EBL)3377979 035 $a(SSID)ssj0000177379 035 $a(PQKBManifestationID)11156206 035 $a(PQKBTitleCode)TC0000177379 035 $a(PQKBWorkID)10211004 035 $a(PQKB)10920734 035 $a(MiAaPQ)EBC3377979 035 $a(Au-PeEL)EBL3377979 035 $a(CaPaEBR)ebr10087004 035 $a(CaONFJC)MIL208350 035 $a(OCoLC)923274861 035 $a(EXLCZ)991000000000030493 100 $a20050908d2005 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aImproving evaluation of anticrime programs$b[electronic resource] /$fCommittee on Improving Evaluation of Anti-Crime Programs, Committee on Law and Justice, Division of Behavioral and Social Sciences and Education, National Research Council of the National Academies 210 $aWashington, D.C. $cNational Academies Press$dc2005 215 $a1 online resource (90 p.) 300 $aDescription based upon print version of record. 311 $a0-309-09706-1 320 $aIncludes bibliographical references (p. 68-72). 327 $a""Front Matter""; ""Preface""; ""Contents""; ""Executive Summary""; ""1 Introduction""; ""2 What Questions Should the Evaluation Address?""; ""3 When Is an Impact Evaluation Appropriate?""; ""4 How Should an Impact Evaluation Be Designed?""; ""5 How Should the Evaluation Be Implemented?""; ""6 What Organizational Infrastructure and Procedures Support High-Quality Evaluation?""; ""7 Summary, Conclusions, and Recommendations: Priorities and Focus""; ""References""; ""Appendixes""; ""Appendix A Biographical Sketches of Committee Members and Staff"" 327 $a""Appendix B Participant List Workshop on Improving Evaluation of Criminal Justice Programs"" 606 $aCrime prevention$zUnited States$xEvaluation 606 $aCriminal justice, Administration of$zUnited States$xEvaluation 608 $aElectronic books. 615 0$aCrime prevention$xEvaluation. 615 0$aCriminal justice, Administration of$xEvaluation. 676 $a364.40973 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910450095303321 996 $aImproving evaluation of anticrime programs$92203473 997 $aUNINA LEADER 00978nam a2200253 i 4500 001 991003647329707536 005 20020509125716.0 008 960321s1995 it ||| | ita 035 $ab11192914-39ule_inst 035 $aPARLA185777$9ExL 040 $aDip.to Scienze pedagogiche$bita 082 0 $a615.822 100 1 $aPearson, Richard$0304176 245 10$aMassaggio psicoterapeutico :$bla ricerca di un metodo :$bla riscoperta dell'io corporeo integrando la massoterapia con il training autogeno /$cRichard Pearson 250 $a2. ed. 260 $aBussolengo :$bDemetra,$c1995 300 $a153 p. ill. ;$c24 cm. 650 4$aMassaggio Terapeutico 907 $a.b11192914$b21-09-06$c28-06-02 912 $a991003647329707536 945 $aLE022 615 PEA01.01$g1$i2022000003902$lle022$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i11342225$z28-06-02 996 $aMassaggio psicoterapeutico$9869403 997 $aUNISALENTO 998 $ale022$b01-01-96$cm$da $e-$fita$git $h0$i1 LEADER 03800nam 2200817z- 450 001 9910557502003321 005 20220111 035 $a(CKB)5400000000044536 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76390 035 $a(oapen)doab76390 035 $a(EXLCZ)995400000000044536 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aEmbedded Pharmacists in Primary Care 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (94 p.) 311 08$a3-0365-0170-3 311 08$a3-0365-0171-1 330 $aAs healthcare delivery moves from a provider-centric approach to a more patient-centric approach, systems and payers need to reimagine how care and team-based care is delivered to patients and reimbursed. Thus, the goal should be to see the right patient, by the right provider, in the right place, for the right price, and where appropriate, with the use of the right pharmaceutical(s) - "5 P's". There continues to be a reduction in physicians that are pursuing primary care roles in the United States, thus exacerbating the ability to meet patient demand. Most patient encounters begin with or end with the prescribing of medication. Thus, a future where pharmacists are embedded in primary care settings allows these pharmacists to collaborate at the point-of-prescribing (i.e., in-clinic) and provides tremendous benefits to providers and patients. The pharmacist workforce is educated at the doctoral level, yet vastly underutilized and can assist in a collaborative approach in primary care. The collection of articles in the Special Issue "Embedded Pharmacists in Primary Care" highlight examples of models that have included pharmacists in the ambulatory setting providing services in chronic disease management, comprehensive medication management, and care of specific conditions such as diabetes. 606 $aMedicine$2bicssc 610 $aacademic 610 $aacademic medical center 610 $aambulatory care 610 $aambulatory pharmacy 610 $achronic care management 610 $aclinical pharmacy 610 $acollaborative practice agreement 610 $acomprehensive medication management 610 $acomprehensive medications management 610 $adiabetes 610 $adissemination 610 $adyslipidemia 610 $aelectronic dashboard 610 $aelectronic health record 610 $aevidence-based pharmacy practice 610 $afamily medicine 610 $agraduate medical education 610 $ahealth outcomes 610 $ahypertension 610 $aimplementation science 610 $ainnovative practice 610 $ainterprofessional 610 $ainterprofessional collaboration 610 $amedical education 610 $an/a 610 $apatient care extender 610 $apharmacist 610 $apharmacist in primary care 610 $apharmacist-physician collaboration 610 $apharmacy 610 $apractice growth 610 $apractice management 610 $apractice transformation 610 $aprimary care 610 $aprimary care team pharmacist 610 $aprimary health care 610 $aquality improvement 610 $ateam-based primary care 615 7$aMedicine 700 $aMacKinnon III$b PhD$4edt$01293420 702 $aLamberton$b PharmD$4edt 702 $aMacKinnon III$b PhD$4oth 702 $aLamberton$b PharmD$4oth 906 $aBOOK 912 $a9910557502003321 996 $aEmbedded Pharmacists in Primary Care$93022606 997 $aUNINA